Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Wallington

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Transfusion Medicine (Oxford, England)|October 5, 2001
Panel Discussion. Millennium Festival of Medicine--Transfusion 2020--18 October 2000M Fogden, K Whitehorn, D Starr, et al.
Leukemia Research|March 13, 2024
Expression of the chemokine receptor CCR1 decreases sensitivity to bortezomib in multiple myeloma cell linesMara N Zeissig, Duncan R Hewett, Krzysztof M Mrozik, et al.
Oncotarget|May 4, 2017
Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stressCraig T Wallington-Beddoe, Melissa K Bennett, Kate Vandyke, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|July 17, 2003
Update: severe acute respiratory syndrome--Toronto, 2003T Wallington, L Berger, B Henry, et al.
Molecular Oncology|July 10, 2021
Desmoglein-2 expression is an independent predictor of poor prognosis patients with multiple myelomaLisa M Ebert, Kate Vandyke, M Zahied Johan, et al.
Neoplasia (New York, N.Y.)|November 26, 2021
Resensitising proteasome inhibitor-resistant myeloma with sphingosine kinase 2 inhibitionMelissa K Bennett, Manjun Li, Melinda N Tea, et al.
Blood|December 14, 2016
Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemiaJason A Powell, Alexander C Lewis, Wenying Zhu, et al.
Vox Sanguinis|August 25, 2001
Universal leucocyte-depletion of blood components: cell concentrates and plasmaC P Engelfriet, H W Reesink, R N Pietersz, et al.
Cancer Cell|June 9, 2023
Circular RNAs drive oncogenic chromosomal translocations within the MLL recombinome in leukemiaVanessa M Conn, Marta Gabryelska, John Toubia, et al.
Blood|April 20, 2022
Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemiaAlexander C Lewis, Victoria S Pope, Melinda N Tea, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Transfusion Medicine (Oxford, England)|October 5, 2001
Panel Discussion. Millennium Festival of Medicine--Transfusion 2020--18 October 2000M Fogden, K Whitehorn, D Starr, et al.
Leukemia Research|March 13, 2024
Expression of the chemokine receptor CCR1 decreases sensitivity to bortezomib in multiple myeloma cell linesMara N Zeissig, Duncan R Hewett, Krzysztof M Mrozik, et al.
Oncotarget|May 4, 2017
Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stressCraig T Wallington-Beddoe, Melissa K Bennett, Kate Vandyke, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|July 17, 2003
Update: severe acute respiratory syndrome--Toronto, 2003T Wallington, L Berger, B Henry, et al.
Molecular Oncology|July 10, 2021
Desmoglein-2 expression is an independent predictor of poor prognosis patients with multiple myelomaLisa M Ebert, Kate Vandyke, M Zahied Johan, et al.
Neoplasia (New York, N.Y.)|November 26, 2021
Resensitising proteasome inhibitor-resistant myeloma with sphingosine kinase 2 inhibitionMelissa K Bennett, Manjun Li, Melinda N Tea, et al.
Blood|December 14, 2016
Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemiaJason A Powell, Alexander C Lewis, Wenying Zhu, et al.
Vox Sanguinis|August 25, 2001
Universal leucocyte-depletion of blood components: cell concentrates and plasmaC P Engelfriet, H W Reesink, R N Pietersz, et al.
Cancer Cell|June 9, 2023
Circular RNAs drive oncogenic chromosomal translocations within the MLL recombinome in leukemiaVanessa M Conn, Marta Gabryelska, John Toubia, et al.
Blood|April 20, 2022
Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemiaAlexander C Lewis, Victoria S Pope, Melinda N Tea, et al.
Pageof 5